Danisco and Kappa Flexing K2 Muscles

March 17, 2011

Danisco (Copenhagen) is strengthening its position in the vitamin K2 market through a new partnership with synthetic vitamin k2 supplier Kappa Bioscience AS (Oslo, Norway).

Danisco (Copenhagen) is strengthening its position in the vitamin K2 market through a new partnership with synthetic vitamin k2 supplier Kappa Bioscience AS (Oslo, Norway).

Rapidly increasing science and market awareness is making vitamin K2 a popular product for heart health and bone health.

Danisco offers a natural form of vitamin K2 MK-7 in its ActivK ingredient; meanwhile, the company says that Kappa Bioscience is established as the first company to have developed a synthetic form of K2 MK-7.

“This new agreement between Danisco and Kappa Bioscience will enable the expansion of Vitamin K2 into broad market segments,” says Peter Wisler, Danisco Health & Nutrition director of business development. “Not only will this aid the availability of a broader format of end products, [sic] it will also increase awareness and education amongst consumers, thus establishing this vitamin alongside many other highly functional and necessary vitamins.”